BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27927042)

  • 21. Methamphetamine-associated cardiomyopathy: an addiction medicine perspective.
    Somma V; Osekowski M; Paratz E; Bonomo Y
    Intern Med J; 2023 Jan; 53(1):21-26. PubMed ID: 36693638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methamphetamine--what primary care practitioners need to know.
    McAvoy BR
    J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
    [No Abstract]   [Full Text] [Related]  

  • 23. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
    Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
    Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health outcomes associated with methamphetamine use among young people: a systematic review.
    Marshall BD; Werb D
    Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 27. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
    van Gorp WG; Hinkin CH
    Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development.
    Courtney KE; Ray LA
    Prog Brain Res; 2016; 223():295-310. PubMed ID: 26806782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence.
    Cook R; Quinn B; Heinzerling K; Shoptaw S
    Addiction; 2017 Jun; 112(6):1077-1085. PubMed ID: 28107598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methamphetamine-induced neural and cognitive changes in rodents.
    Marshall JF; Belcher AM; Feinstein EM; O'Dell SJ
    Addiction; 2007 Apr; 102 Suppl 1():61-9. PubMed ID: 17493054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine and meth mouth: an overview.
    Williams N; Covington JS
    J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current data on methamphetamine].
    Cottencin O; Rolland B; Guardia D; Karila L
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine development against methamphetamine drug addiction.
    Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V
    Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will the methamphetamine problem go away?
    Rawson RA; Anglin MD; Ling W
    J Addict Dis; 2002; 21(1):5-19. PubMed ID: 11831500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature.
    Leidl D; Takhar P; Li H
    Int J Ment Health Nurs; 2023 Oct; 32(5):1225-1242. PubMed ID: 36978242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems.
    Lim MS; Cogger S; Quinn B; Hellard ME; Dietze PM
    Aust N Z J Public Health; 2015 Apr; 39(2):194-5. PubMed ID: 25559677
    [No Abstract]   [Full Text] [Related]  

  • 39. "Tweaking and geeking, just having some fun": an analysis of methamphetamine poems.
    Sexton RL; Carlson RG; Leukefeld CG; Booth BM
    J Psychoactive Drugs; 2010 Sep; 42(3):377-83. PubMed ID: 21053760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The need for speed: an update on methamphetamine addiction.
    Barr AM; Panenka WJ; MacEwan GW; Thornton AE; Lang DJ; Honer WG; Lecomte T
    J Psychiatry Neurosci; 2006 Sep; 31(5):301-13. PubMed ID: 16951733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.